Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2).

@article{Waldinger2011HyposensitizationTW,
  title={Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2).},
  author={M. Waldinger and M. Meinardi and D. Schweitzer},
  journal={The journal of sexual medicine},
  year={2011},
  volume={8 4},
  pages={
          1171-6
        }
}
  • M. Waldinger, M. Meinardi, D. Schweitzer
  • Published 2011
  • Medicine
  • The journal of sexual medicine
  • INTRODUCTION Postorgasmic illness syndrome (POIS) is a post-ejaculatory complex of local and/or systemic symptoms that nearly always occurs within seconds, minutes, or hours post-masturbation, coitus, or spontaneous ejaculation. Recent data suggest an autoimmunogenic/allergic underlying mechanism. AIM To treat males with POIS by hyposensitization with their own semen (autologous semen). METHODS Two males suffering from POIS, of which one male with coincidental lifelong premature ejaculation… CONTINUE READING
    34 Citations
    Intralymphatic Immunotherapy With Autologous Semen in a Korean Man With Post-Orgasmic Illness Syndrome
    • 10
    • Highly Influenced
    Negative allergy study in a case of postorgasmic illness syndrome (POIS).
    • 4
    Post orgasmic illness syndrome (POIS)
    • 15
    • PDF
    Postorgasmic illness syndrome: semen allergy in men.
    • 3
    Post-Orgasmic Illness Syndrome: A Review.
    • 11
    Clinical experience with post-orgasmic illness syndrome (POIS) patients—characteristics and possible treatment modality
    • Y. Reisman
    • Medicine
    • International Journal of Impotence Research
    • 2020
    • 2
    • Highly Influenced

    References

    SHOWING 1-10 OF 14 REFERENCES
    Postorgasm illness syndrome--a spectrum of illnesses.
    • 25
    Postorgasmic Illness Syndrome: Two Cases
    • 47
    Allergen injection immunotherapy for seasonal allergic rhinitis.
    • 609
    Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation*
    • 554
    • PDF